Scott H. Stewart, MD
Dr. Stewart completed training in internal medicine at the University of Pittsburgh in 1996. He spent the next 3 years as a community physician in Maine, where he first developed specific interests in alcohol-related disorders. After completing a two-year Academic Generalist Fellowship at MUSC, he was a member of the Department of Medicine at the University at Buffalo for five years. He then returned to MUSC with a primary appointment in the Center for Drug and Alcohol Programs. He has collaborated with a number of clinical divisions on the validation of alcohol biomarkers and detection of potentially
alcohol-related health problems, and serves as a general internal medicine consultant for inpatients at the Institute of Psychiatry.
| ||OBJECTIVES |
| ||At the completion of this session, the participant will be able to:|
1. Discuss newer biomarkers of alcohol consumption that are being used clinically in some settings or are on the
threshold of clinical use.
2. Identify the strengths and weaknesses of novel alcohol consumption biomarkers (i.e., know what a specific test result does
and does not indicate about a patient’s use of alcohol).